Page 1 of 1
6/6/2013
New Center of Excellence Significantly Enhances Hypotube Manufacturing Capabilities
5/6/2013
ETView Ltd. received FDA Clearance of a 510(k) Pre-marketing Notification Application for the VivaSight-DL Line
4/25/2013
Curie-Cancer and Vygon partnership look to develop innovative devices, mainly for use in chemotherapy.
Page 1 of 1